Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Tumor cell-selective cytotoxicity by targeting cell cycle checkpoints.

Robyn Warrener1, Heather Beamish, Andrew Burgess

  • 1Cancer Biology Program, Centre for Immunology and Cancer Research, University of Queensland, Brisbane, Queensland. 4102, Australia.

FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology
|June 26, 2003
PubMed
Summary

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

S-phase targeted treatment triggers caspase-dependent lytic immunogenic cell death with pyroptotic features in cancers.

Cell death and differentiation·2026
Same author

Using targeted therapy to promote a pro-inflammatory tumour microenvironment and anti-tumour immune response in high grade serous ovarian cancer.

British journal of cancer·2026
Same author

Tetraploids or polyploid giants: who is truly dangerous?

Trends in cell biology·2026
Same author

Checkpoint Kinase 1 Inhibitor Combined with Low Dose Hydroxyurea Promotes ATM-Activated NF-κB-Dependent Pro-Inflammatory Chemokine Expression in Melanomas.

Cancers·2025
Same author

Aurora B inhibition induces hyper-polyploidy and loss of long-term proliferative potential in RB and p53 defective cells.

Cell death & disease·2025
Same author

Aurora B inhibitors promote RB hypophosphorylation and senescence independent of p53-dependent CDK2/4 inhibition.

Cell death & disease·2024

Histone deacetylase inhibitors are cytotoxic to cancer cells by disrupting two cell cycle checkpoints. This leads to aberrant mitosis and apoptosis, offering a targeted chemotherapy approach.

Area of Science:

  • Molecular Biology
  • Cell Biology
  • Cancer Research

Background:

  • Cell cycle checkpoints are crucial for maintaining genomic integrity.
  • Defective cell cycle checkpoints are common in cancer cells.
  • Targeting these defects offers a strategy for selective cancer therapy.

Purpose of the Study:

  • To investigate the molecular basis of tumor-selective cytotoxicity of histone deacetylase inhibitors.
  • To demonstrate how these drugs disrupt critical cell cycle checkpoints.

Main Methods:

  • Investigated the effects of histone deacetylase inhibitors on cell cycle checkpoints.
  • Analyzed the disruption of the G2-phase and mitotic spindle checkpoints.
  • Examined the downstream effects on mitosis and cell death.

Related Experiment Videos

Main Results:

  • Histone deacetylase inhibitors disrupt the G2-phase checkpoint in drug-sensitive cells, leading to aberrant mitosis.
  • These drugs also cause a bypass of the mitotic spindle checkpoint.
  • Disruption of both checkpoints results in premature exit from mitosis and apoptosis.

Conclusions:

  • Histone deacetylase inhibitors exhibit tumor-selective cytotoxicity by exploiting defects in multiple cell cycle checkpoints.
  • Targeting cell cycle checkpoints with drugs like histone deacetylase inhibitors provides a promising avenue for developing effective chemotherapeutic agents.